Advertisement

Extracorporeal Photochemotherapy in the Treatment of Cutaneous T Cell Lymphoma

  • A. Konstantinow
  • B.-R. Balda
Conference paper

Abstract

Cutaneous T cell lymphoma (CTCL) and its leukemic erythrodermic form (Sézary syndrome) are malignancies of CD4+ T lymphocytes. Extracorporeal photochemotherapy (ECP) selectively affects autoreactive as well as malignant T lymphocytes. The efficacy of ECP depends strongly upon adequate serum/buffy coat levels of the photosensitizer 8-methoxypsoralen (8-MOP). The resorption of orally applied 8-MOP varies inter- and intraindividually within a broad range, meaning that sufficient therapeutic drug levels cannot always be achieved. Therefore, since July 1994 we have exclusively used a liquid 8-MOP preparation which is added directly into the buffy coat fraction of the ECP circuit, resulting in constant high drug levels of approximately 190 ng/ml. Twelve CTCL patients (six with Sézary syndrome, six with mycosis fungoides) received between six and 25 ECP treatments. Some of them had already prior therapy without success.

All patients with Sézary syndrome declared a destinct reduction of pruritus intensity. Three patients who received liquid 8-MOP extracorporeally showed a partial remission on the basis of skin scores. From the patients receiving 8-MOP orally two remained clinically unchanged, on showed a progression of the disease. In these cases, subtherapeutic 8-MOP plasma levels were often found. From the six mycosis fungoides patients, one achieved a complete, two a partial remission, and another two patients a minor response. This five patients were treated with liquid 8-MOP. One patient showed no change in skin lesions. He received 8-MOP orally and achieved subtherapeutic photosensitizer plasma levels.

Our treatment protocols confirm the beneficial effects of ECP on CTCL at any stage, but it seems that ECP efficiency is ensured only when a 8-MOP solution is applied extracorporeally.

Keywords

Partial Remission Mycosis Fungoides Minor Response Skin Score Sezary Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Broder S, Edelson RL, Lutzner et al. (1976) The Sézary syndrome: a malignant proliferation of helper T cells. J Clin Invest 58: 1297–1306PubMedCrossRefGoogle Scholar
  2. Ralfkiaer E, Wolff-Sneedorff A, Thomsen K, et al.(1993) Immunophenotypic studies in cutaneous T-cell lymphomas: Clinical implications. Br J Dermatol 129: 655–659PubMedCrossRefGoogle Scholar
  3. Kaye FJ, Bunn PA, Steinberg SM, et al. (1989) A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides. N Engl J Med 321: 1784–1790PubMedCrossRefGoogle Scholar
  4. Weinstock MA, Horm JW (1988) Population-based estimate of survival and determinants of prognosis with mycosis fungoides. Cancer 62: 1658–1661PubMedCrossRefGoogle Scholar
  5. Kerl H, Volkenandt M, Cerroni L (1994) Maligne Lymphome der Haut. Hautarzt 45:421–443PubMedCrossRefGoogle Scholar
  6. Wieselthier JS, Koh HK (1990) Sézary syndrome: diagnosis, prognosis, and critical review of treatment options. J Am Acad Dermatol 22: 381–401PubMedCrossRefGoogle Scholar
  7. Edelson RL, Berger C, Gasparro F et al. (1987) Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results. N Engl. J Med 316: 297–303PubMedCrossRefGoogle Scholar
  8. Heald P, Rook A. Perez M et al. (1992) Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapy. J Am Acad Dermatol 27: 427–433PubMedCrossRefGoogle Scholar
  9. Edelson RL, Heald P, Perez M et al. (1994) Extracorporeal Photochemotherapy. Biol Ther Cancer Updates 4:1–12Google Scholar
  10. Knobler RM, Trautinger F, Graninger W et al. (1993) Parenteral administration of 8-methoxypsoralen in photopheresis. J Am Acad Dermatol 28: 580–584PubMedCrossRefGoogle Scholar
  11. Balda BR, Konstantinow A, Starz H et al. (1996) Extracorporeal photochemotherapy as an effective treatment modality in chronic graft-versus-host disease. J Eur Acad Derm Venerol 7: 155–162CrossRefGoogle Scholar
  12. Konstantinow A, Balda BR, Starz H et al. (1996) Chronic graft-versus-host disease: successful treatment with extracorporeal photochemotherapy: a follow-up Br J Dermatol 135: 1007–1008PubMedCrossRefGoogle Scholar
  13. Meiser BM, Kur F, Reichenspurner H et al. (1994) Reduction of the incidence of rejection by adjunct immunosuppression with photochemotherapy after heart transplantation. Transplantation 57: 563–568PubMedGoogle Scholar
  14. Goldman BD, Oh SK, Davis BE et al. (1993) Serum Soluble Interleukin 2 Receptor Levels in Erythrodermic Cutaneous T-Cell Lymphoma Correlate With Response to Photopheresis-Based Treatment. Arch Dermatol 129: 1166–1170PubMedCrossRefGoogle Scholar
  15. Edelson R, Heald P, Perez M et al. (1991) Photopheresis update. Progr Dermatol 25: 1–6Google Scholar
  16. Green SB, Byar DP, Lamberg SI (1981) Prognostic variables in mycosis fungoides. Cancer 47:2671–2677PubMedCrossRefGoogle Scholar
  17. Zic J, Arzubiaga C, Salhany KE et al. (1992) Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma. J Am Acad Dermatol 27: 729–736PubMedCrossRefGoogle Scholar
  18. KimYH, Bishop K, Varghese A et al. (1995) Prognostic Factors in Erythrodermic Mycosis Fungoides and the Sezary Syndrome. Arch Dermatol 131: 1003–1008PubMedCrossRefGoogle Scholar
  19. Bernengo MG, Fierro MT, Novelli M et al. (1993) Soluble interleukin-2 receptor in Sézary syndrome: its origin and clinical application. Br J Dermatol 128: 124–129PubMedCrossRefGoogle Scholar
  20. Greene WC, Leonard WJ, Depper JM et al. (1986) The human interleukin-2 receptor: normal and abnormal expression in T cells and in leukemias induced by the human T-lym- photropic retroviruses. Ann Intern Med 105: 560–572PubMedGoogle Scholar
  21. Heald P, Yan SL, Edelson R (1994) Profound Deficiency in Normal Circulating T Cells in Erythrodermic Cutaneous T-Cell Lymphoma. Arch Dermatol 130: 198–203PubMedCrossRefGoogle Scholar
  22. Mc Nutt SN, Crain WR (1981) Quantitative electron microscopic comparison of lymphocyte nuclear contours in mycosis fungoides and in benign infiltrates in skin. Cancer 47: 698–702CrossRefGoogle Scholar
  23. Reinhold U, Herpertz M, Kukel S et al. (1994) Induction of Nuclear Contour Irregularity During T-Cell Activation Via the T-Cell Receptor/CD3 Complex and CD2 Antigens in the Presence of Phorbol Esters. Blood 83: 703–706PubMedGoogle Scholar
  24. Honigsmann H, Jaschke E, Nitsche V et al. (1982) Serum levels of 8-methoxypsoralen in two different drug preparations: correlation with photosensitivity and UV-A dose requirements for photochemotherapy. J Invest Dermatol 79: 233–236CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1997

Authors and Affiliations

  • A. Konstantinow
  • B.-R. Balda

There are no affiliations available

Personalised recommendations